The Zhitong Finance App learned that Sinopharm Holdings (01099) rose more than 5%, temporarily leading the promotion of blue-chip stocks. As of press release, it rose 5.41% to HK$16.17, with a turnover of approximately HK$805.257 million.

According to the news, Sinopharm Holdings announced results for the nine months ended September 30, 2026. The company achieved operating income of 427.613 billion yuan, a year-on-year decrease of 0.9%; net profit to mother was 5.314 billion yuan, an increase of 0.13% over the previous year. Revenue for the third quarter was 144.814 billion yuan, and the year-on-year decline narrowed to 0.43%; net profit to mother for the single quarter was 1,910 billion yuan, up 3.74% year on year. In the first three quarters, sales, management and financial expenses decreased by 5.93%, 3.41% and 20.95% respectively, while credit impairment losses narrowed from $1,901 billion to $1,583 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.